From January 1, 2025 to March 31, 2025, the company has repurchased 40,000 shares, representing 0.004383% for CNY 1.09 million. With this, the company has completed the repurchase of 220,500 shares, representing 0.02% for CNY 6.1 million under the buyback announced on July 23, 2024.
Tranche Update on Hubei Jumpcan Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on July 23, 2024.
Published on 04/02/2025
S&P Capital IQ
Share
© S&P Capital IQ -
2025
Share

















